{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2013-N-0500\" sorted by posted_date descending", "rows": [["FDA-2013-N-0500-0143", "FDA", "FDA-2013-N-0500", "03- Reference 02- U.S. Department of Health and Human Services, Food and Drug Administration, \u201cFiscal Year 2019 Justification of Estimates for Appropriations Committees", "Supporting & Related Material", "Background Material", "2018-12-14T05:00:00Z", 2018, 12, null, null, "2018-12-14T15:14:01Z", null, 0, 0, "09000064839949a4"], ["FDA-2013-N-0500-0141", "FDA", "FDA-2013-N-0500", "01-List of References Withdrawal of Proposed Rule on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products", "Supporting & Related Material", "Background Material", "2018-12-14T05:00:00Z", 2018, 12, null, null, "2018-12-14T15:12:24Z", null, 0, 0, "09000064839949a2"], ["FDA-2013-N-0500-0140", "FDA", "FDA-2013-N-0500", "Withdrawal of Proposed Rule on Supplemental Applications Proposing\nLabeling Changes for Approved Drugs and Biological Products", "Proposed Rule", "Withdrawal", "2018-12-14T05:00:00Z", 2018, 12, "2018-12-14T05:00:00Z", null, "2018-12-14T14:36:07Z", "2018-27098", 0, 0, "09000064839936bc"], ["FDA-2013-N-0500-0142", "FDA", "FDA-2013-N-0500", "02- Reference 01- Draft guidance for industry, \u201cUpdating ANDA Labeling After the Marketing Application for the Reference Listed Drug Has Been Withdrawn,\u201d", "Supporting & Related Material", "Background Material", "2018-12-14T05:00:00Z", 2018, 12, null, null, "2018-12-14T15:13:06Z", null, 0, 0, "09000064839949a3"], ["FDA-2013-N-0500-0139", "FDA", "FDA-2013-N-0500", "Attachment 1 Record of Comments from March 13, 2014 re: Supplemental Comment from Washington Legal Foundation", "Supporting & Related Material", "Background Material", "2016-04-26T04:00:00Z", 2016, 4, null, null, "2016-04-26T18:45:51Z", null, 0, 0, "0900006481f8f7d2"], ["FDA-2013-N-0500-0136", "FDA", "FDA-2013-N-0500", "Slide Presentations from the March 27 2015 Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Public Meeting Redacted", "Other", "Presentation", "2015-04-29T04:00:00Z", 2015, 4, "2015-04-29T04:00:00Z", null, "2015-04-29T13:25:10Z", null, 0, 0, "0900006481abfea0"], ["FDA-2013-N-0500-0111", "FDA", "FDA-2013-N-0500", "Agenda for March 27 2015 Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Public Meeting", "Other", "Agenda", "2015-04-24T04:00:00Z", 2015, 4, "2015-04-24T04:00:00Z", null, "2015-04-24T20:16:35Z", null, 0, 0, "0900006481ab9bdf"], ["FDA-2013-N-0500-0112", "FDA", "FDA-2013-N-0500", "Transcript of March 27 2015 Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Public Meeting", "Other", "Transcript(s)", "2015-04-24T04:00:00Z", 2015, 4, "2015-04-24T04:00:00Z", null, "2015-04-24T21:01:09Z", null, 0, 0, "0900006481aba131"], ["FDA-2013-N-0500-0105", "FDA", "FDA-2013-N-0500", "Briefs Submitted in Teva Pharmaceuticals USA, Inc. v. Superior Court of Orange County", "Supporting & Related Material", "Brief", "2015-04-03T04:00:00Z", 2015, 4, null, null, "2015-04-03T19:17:49Z", null, 0, 0, "0900006481a8b7a5"], ["FDA-2013-N-0500-0081", "FDA", "FDA-2013-N-0500", "Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products; Public Meeting; Request for Comments;\nReopening of the Comment Period", "Proposed Rule", "Public Meeting", "2015-02-18T05:00:00Z", 2015, 2, "2015-02-18T05:00:00Z", "2015-04-28T03:59:59Z", "2015-05-07T01:31:29Z", "2015-03211", 0, 0, "0900006481a078f5"], ["FDA-2013-N-0500-0082", "FDA", "FDA-2013-N-0500", "Reference 1 - Joint GPhA PhRMA Letter to Dr Hamburg re Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products; Public Meeting; Request for Comments;\nReopening of the Comment Period", "Supporting & Related Material", "Background Material", "2015-02-18T05:00:00Z", 2015, 2, null, null, "2015-02-18T18:01:50Z", null, 0, 0, "0900006481a0854b"], ["FDA-2013-N-0500-0080", "FDA", "FDA-2013-N-0500", "Memorandum of Meeting with GPhA (September 8, 2014)", "Other", "Memorandum", "2014-12-17T05:00:00Z", 2014, 12, "2014-12-17T05:00:00Z", null, "2014-12-19T20:58:41Z", null, 0, 0, "090000648197f44a"], ["FDA-2013-N-0500-0079", "FDA", "FDA-2013-N-0500", "Supplement from the Generic Pharmaceutical Association", "Other", "Supplement (SUP)", "2014-07-18T04:00:00Z", 2014, 7, "2014-07-18T04:00:00Z", null, "2014-07-18T13:56:52Z", null, 0, 0, "0900006481775a8b"], ["FDA-2013-N-0500-0078", "FDA", "FDA-2013-N-0500", "Attachment 3 Revised Virilon Package Insert with Changes Highlighted Supplement from Star Pharmaceuticals, Inc.", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-16T20:38:52Z", null, 0, 0, "090000648171fbc5"], ["FDA-2013-N-0500-0075", "FDA", "FDA-2013-N-0500", "Supplement from Star Pharmaceuticals, Inc.", "Other", "Supplement (SUP)", "2014-06-05T04:00:00Z", 2014, 6, "2014-06-05T04:00:00Z", null, "2014-06-05T19:03:19Z", null, 0, 0, "090000648171fd33"], ["FDA-2013-N-0500-0077", "FDA", "FDA-2013-N-0500", "Attachment 2 Revised Virilon Package Insert re Supplement from Star Pharmaceuticals, Inc.", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-10-24T19:16:16Z", null, 0, 0, "090000648171fbc4"], ["FDA-2013-N-0500-0076", "FDA", "FDA-2013-N-0500", "Attachment 1 Virilon Drug Listing re Supplement from Star Pharmaceuticals, Inc.", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-10-24T19:15:34Z", null, 0, 0, "090000648171fad3"], ["FDA-2013-N-0500-0010", "FDA", "FDA-2013-N-0500", "Request for Extension from Biotechnology Industry Organization (BIO) and Pharmaceutical Research and Manufacturers of America (PhRMA)", "Other", "Request for Extension", "2014-02-10T05:00:00Z", 2014, 2, "2014-02-10T05:00:00Z", null, "2016-10-31T13:21:42Z", null, 0, 0, "09000064814c6d0a"], ["FDA-2013-N-0500-0009", "FDA", "FDA-2013-N-0500", "Request for Extension from Mylan", "Other", "Request for Extension", "2014-02-10T05:00:00Z", 2014, 2, "2014-02-10T05:00:00Z", null, "2016-10-31T13:21:42Z", null, 0, 0, "09000064814c5e12"], ["FDA-2013-N-0500-0011", "FDA", "FDA-2013-N-0500", "Request for Extension from Perrigo", "Other", "Request for Extension", "2014-02-10T05:00:00Z", 2014, 2, "2014-02-10T05:00:00Z", null, "2016-10-31T13:21:44Z", null, 0, 0, "09000064814ca396"], ["FDA-2013-N-0500-0008", "FDA", "FDA-2013-N-0500", "Request for Extension from Academy of Managed Care Pharmacy (AMCP) et al", "Other", "Request for Extension", "2014-02-10T05:00:00Z", 2014, 2, null, null, "2016-10-31T13:21:41Z", null, 0, 0, "09000064814c4f5c"], ["FDA-2013-N-0500-0007", "FDA", "FDA-2013-N-0500", "Request for Extension from Perrigo", "Other", "Request for Extension", "2014-02-10T05:00:00Z", 2014, 2, "2014-02-10T05:00:00Z", null, "2016-10-31T13:21:40Z", null, 0, 0, "09000064814b4789"], ["FDA-2013-N-0500-0006", "FDA", "FDA-2013-N-0500", "Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products; Correction and Extension of Comment Period", "Proposed Rule", "Extension of Comment Period", "2013-12-27T05:00:00Z", 2013, 12, "2013-12-27T05:00:00Z", "2014-03-14T03:59:59Z", "2014-04-10T01:02:03Z", "2013-30881", 0, 0, "09000064814debad"], ["FDA-2013-N-0500-0005", "FDA", "FDA-2013-N-0500", "OMB Review Proposed Rule re Executive Order 12866, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products 11-13-2013 - Memorandum", "Other", "Memorandum", "2013-12-13T05:00:00Z", 2013, 12, "2013-12-13T05:00:00Z", null, "2013-12-13T16:08:47Z", null, 0, 0, "09000064814bc8a9"], ["FDA-2013-N-0500-0004", "FDA", "FDA-2013-N-0500", "Generic Pharmaceutical Association (GPhA) - Request for Extension of Comment Period", "Other", "Request for Extension", "2013-12-04T05:00:00Z", 2013, 12, "2013-12-04T05:00:00Z", null, "2013-12-04T20:09:50Z", null, 0, 0, "090000648149a218"], ["FDA-2013-N-0500-0002", "FDA", "FDA-2013-N-0500", "OMB Review Proposed Rule re Executive Order 12866, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products 11-13-2013 - Memorandum", "Other", null, "2013-11-21T00:00:00Z", 2013, 11, null, null, "2013-11-25T14:34:53Z", null, 0, 1, "090000648148e9e1"], ["FDA-2013-N-0500-0001", "FDA", "FDA-2013-N-0500", "Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2013-11-13T05:00:00Z", 2013, 11, "2013-11-13T05:00:00Z", "2014-01-14T04:59:59Z", "2016-04-26T19:00:32Z", "2013-26799", 0, 0, "090000648147a982"]], "truncated": false, "filtered_table_rows_count": 27, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2013-N-0500"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500", "results": [{"value": "FDA", "label": "FDA", "count": 27, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-N-0500", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500", "results": [{"value": "Other", "label": "Other", "count": 14, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500&document_type=Other", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 9, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500", "results": [{"value": 2014, "label": 2014, "count": 11, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500&posted_year=2014", "selected": false}, {"value": 2015, "label": 2015, "count": 6, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500&posted_year=2015", "selected": false}, {"value": 2013, "label": 2013, "count": 5, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500&posted_year=2013", "selected": false}, {"value": 2018, "label": 2018, "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500&posted_year=2018", "selected": false}, {"value": 2016, "label": 2016, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500&posted_year=2016", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "title", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500&_facet=title"}, {"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500&_facet=comment_start_date"}, {"name": "last_modified", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500&_facet=last_modified"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2013-N-0500&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 640.8484908752143, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}